Vitiligo patients from India (Mumbai) show differences in clinical,demographic and autoantibody profiles compared to patients in western countries

Background Vitiligo is a common, idiopathic skin disorder characterized by depigmented skin due to the loss of cutaneous melanocytes. Several studies have reported the clinical and demographic characteristics of Indian vitiligo patients, however, none has characterized their antibody profiles. Objective To establish the clinical, demographic and serological details of a population of vitiligo patients from Mumbai, India, and to evaluate the data for any associations between clinical presentations and the occurrence of antibody responses. Methods Vitiligo patients (n = 79) were recruited to the study and their clinical and demographic details recorded. Serum antibodies, including those against melanocyte‐specific antigens, thyroid antigens and keratinocytes, were evaluated. Results The prevalence of vitiligo was independent of sex, and non‐segmental vitiligo was the most common form of the disease occurring in 65% of the patients. Patients with segmental vitiligo (mean age = 14.4 ± 4.6 years) presented at a younger age than those with non‐segmental disease (mean age = 32.5 ± 17.8 years). Personal and family histories of other autoimmune diseases occurred in 3% and 8% of patients, respectively. Antibodies were detected against tyrosinase, tyrosine hydroxylase, thyroid peroxidase, thyroglobulin and keratinocytes at frequencies of 11%, 22%, 18%, 24% and 27%, respectively. Overall, antibodies were more common in patients with non‐segmental vitiligo (50–67%) than in those with segmental disease (0–17%), and were detected more frequently in patients with shorter disease durations (<10 years). Conclusion Our study provides novel information relative to the clinical details, demographic features and serological parameters of a population of vitiligo patients from Mumbai, India. Important distinctions from similar surveys conducted in European patients were evident such as an infrequency of family history, a low prevalence of clinical autoimmune disease, and an absence of particular antibody specificities. These differences may have a bearing on the pathogenesis and course of the disease in Indian patients.     

Functional studies on c.1347C>T,a polymorphism modulating phenotypic outcome in X-linked adrenoleukodystrophy

Tijdschrift voor Kindergeneeskunde -     

Decreasing the burden in families caring for a relative with a dementing illness. A controlled study

The purpose of this study was to investigate the efficacy of a specifically designed group support program for relatives of patients with Alzheimer's disease and related disorders. The group program included educational/supportive activities and used basic principles of the cognitive-behavioral approach. Twenty-two subjects participated in an eight-session program. Eighteen control subjects received no treatment. Measures of family burden, levels of depression, and knowledge of dementia were obtained. Experimental subjects showed a significant decrease in total family burden, whereas control subjects actually showed a significant increase, experimental subjects also showed reduction in their levels of depression. Experimental subjects showed a significantly greater improvement than did control subjects on knowledge of dementia. The acquisition of new knowledge was an important ingredient in reducing perception of burden and levels of depression, but other facets of the intervention also accounted for the improvement. Results indicated that a relatively short but intensive support experience can have a positive effect in reducing some of the burden and depression associated with the care of a demented relative.     

N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding.

Syu et al. recently reported that deletion of residues Ile-108 to Leu-116 from the amino terminus of gp120 abolished CD4 binding. The authors have investigated the role of this region using a monospecific antipeptide antibody. As assessed by a microtiter plate-based radioimmunoassay, the antibody, raised in sheep against a synthetic peptide encompassing this deleted region, does not inhibit the gp120-CD4 association. The reported loss of CD4 binding ability, resulting from the deletion in this region of gp120, is likely to be due to indirect structural changes in gp120 rather than representing an integral part of the CD4 binding domain.     

The association of quadriceps strength with the knee adduction moment in medial knee osteoarthritis

Objective

To investigate the relationship between quadriceps strength and the peak knee adduction moment during walking in medial tibiofemoral osteoarthritis (OA), and whether varus malalignment influences this relationship.

Methods

Maximum isometric quadriceps strength at 60° flexion relative to body mass and the peak knee adduction moment during walking were assessed in 184 community volunteers with medial knee OA. Mechanical knee alignment was determined either directly from full‐leg radiograph or extrapolated from anatomic alignment on knee radiograph using regression equations. Pearson's correlation coefficient was used to assess the association between quadriceps strength and peak knee adduction moment. The independent relationship between quadriceps strength and peak knee adduction moment, and the impact of varus malalignment on this relationship, was assessed using multiple regression analyses with and without adjustment for covariates.

Results

Quadriceps strength was not significantly associated with peak knee adduction moment (r = 0.14, P = 0.059). Neither quadriceps strength (b = 0.25, P = 0.142) nor the interaction between quadriceps strength and varus malalignment (b = ?0.01, P = 0.693) significantly contributed to the variance in peak knee adduction moment. Results were unchanged with the inclusion of covariates.

Conclusion

No significant association was observed between quadriceps strength and the peak knee adduction moment, and the severity of varus malalignment did not influence the relationship. Results suggest that clinicians should not be concerned that patients with knee OA and stronger quadriceps are more likely to demonstrate a higher knee adduction moment.